Eur Respir J. 2012 Jun;39(6):1534-5.
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.
Frydman N, Steffann J, Girerd B, Frydman R, Munnich A, Simonneau G, Humbert M.
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.
Frydman N, Steffann J, Girerd B, Frydman R, Munnich A, Simonneau G, Humbert M.
Eur Respir J. 2012 Jun;39(6):1549-50.
EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism.
Montani D, Jaïs X, Sitbon O, Dartevelle P, Simonneau G, Humbert M.
EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism.
Montani D, Jaïs X, Sitbon O, Dartevelle P, Simonneau G, Humbert M.
Arthritis Rheum. 2012 Jun;64(6):2051-2. doi: 10.1002/art.34408. Epub 2012 Jan 31.
Could the Cochin risk prediction score be applied in daily practice to predict pulmonary hypertension in systemic sclerosis? Comment on the article by Meune et al.
Hachulla E, Clerson P, Humbert M.
Could the Cochin risk prediction score be applied in daily practice to predict pulmonary hypertension in systemic sclerosis? Comment on the article by Meune et al.
Hachulla E, Clerson P, Humbert M.
Presse Med. 2012 Jun;41(6 Pt 2):e303-16. Epub 2012 May 18.
Pulmonary hypertension complicating sarcoidosis.
Nunes H, Uzunhan Y, Freynet O, Humbert M, Brillet PY, Kambouchner M, Valeyre D.
Pulmonary hypertension complicating sarcoidosis.
Nunes H, Uzunhan Y, Freynet O, Humbert M, Brillet PY, Kambouchner M, Valeyre D.
Presse Med. 2012 Jun;41(6 Pt 2):e273-4.
Everything you always wanted to know about sarcoidosis... but were afraid to ask.
Valeyre D, Humbert M.
Everything you always wanted to know about sarcoidosis... but were afraid to ask.
Valeyre D, Humbert M.
Presse Med. 2012 Jun 26. [Epub ahead of print]
[Pulmonary arterial hypertension and sickle cell disease.][Article in French]
Savale L, Maitre B, Bachir D, Galactéros F, Simonneau G, Parent F.
Am J Respir Crit Care Med. 2012 Jul 1;186(1):107.
Plasma levels of high-density lipoprotein cholesterol are not associated with survival in pulmonary arterial hypertension.
Cracowski JL, Labarère J, Renversez JC, Degano B, Chabot F, Humbert M.
Eur Respir J. 2012 Jul;40(1):75-83. Epub 2011 Nov 16.
Ventilation/perfusion lung scan in pulmonary veno-occlusive disease.
Seferian A, Helal B, Jaïs X, Girerd B, Price LC, Günther S, Savale L, Dorfmüller P, Parent F, Sitbon O, Humbert M, Simonneau G, Montani D.
J Am Coll Cardiol. 2012 Jul 10. [Epub ahead of print]
Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-Blind 52-Week Uncontrolled Extension Study.
Oudiz RJ, Brundage BH, Galiè N, Ghofrani HA, Simonneau G, Botros FT, Chan M, Beardsworth A, Barst RJ; PHIRST Study Group.
Tadalafil for the Treatment of Pulmonary Arterial Hypertension: A Double-Blind 52-Week Uncontrolled Extension Study.
Oudiz RJ, Brundage BH, Galiè N, Ghofrani HA, Simonneau G, Botros FT, Chan M, Beardsworth A, Barst RJ; PHIRST Study Group.
Eur Respir J. 2012 Jul 12. [Epub ahead of print]
Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension.
Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L, Sitbon O, Simonneau G, Humbert M, Similowski T.